These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18485081)

  • 1. High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism.
    Tripodi A; Legnani C; Chantarangkul V; Cosmi B; Palareti G; Mannucci PM
    J Thromb Haemost; 2008 Aug; 6(8):1327-33. PubMed ID: 18485081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal Protac-induced coagulation inhibition chromogenic assay results are associated with an increased risk of recurrent venous thromboembolism.
    Tripodi A; Legnani C; Lemma L; Cosmi B; Palareti G; Chantarangkul V; Mannucci PM
    J Thromb Thrombolysis; 2010 Aug; 30(2):215-9. PubMed ID: 20419336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation.
    Hron G; Kollars M; Binder BR; Eichinger S; Kyrle PA
    JAMA; 2006 Jul; 296(4):397-402. PubMed ID: 16868297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial.
    Orsi FA; Biedermann JS; Kruip MJHA; van der Meer FJ; Rosendaal FR; van Hylckama Vlieg A; Bos MHA; Leebeek FWG; Cannegieter SC; Lijfering WM
    J Thromb Haemost; 2019 Feb; 17(2):319-328. PubMed ID: 30565854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endogenous thrombin potential and the risk of venous thromboembolism.
    Tripodi A; Martinelli I; Chantarangkul V; Battaglioli T; Clerici M; Mannucci PM
    Thromb Res; 2007; 121(3):353-9. PubMed ID: 17560633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18-65 years.
    Sonnevi K; Tchaikovski SN; Holmström M; Rosing J; Bremme K; Lärfars G
    Thromb Haemost; 2011 Nov; 106(5):901-7. PubMed ID: 21947267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism: risk factors for recurrence.
    Zhu T; Martinez I; Emmerich J
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early thrombin formation capacity in trauma patients and association with venous thromboembolism.
    Voils SA; Lemon SJ; Jordan J; Riley P; Frye R
    Thromb Res; 2016 Nov; 147():13-15. PubMed ID: 27664391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study.
    Kyrle PA; Kammer M; Eischer L; Weltermann A; Minar E; Hirschl M; Heinze G; Eichinger S
    J Thromb Haemost; 2016 Dec; 14(12):2402-2409. PubMed ID: 27696701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis.
    Tripodi A; Primignani M; Lemma L; Chantarangkul V; Mannucci PM
    J Hepatol; 2013 Aug; 59(2):265-70. PubMed ID: 23583273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of recurrent venous thromboembolism after discontinuation of vitamin K antagonist treatment: a nested case-control study.
    Martinez C; Katholing A; Folkerts K; Cohen AT
    J Thromb Haemost; 2016 Jul; 14(7):1374-83. PubMed ID: 27079164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.
    Novacek G; Weltermann A; Sobala A; Tilg H; Petritsch W; Reinisch W; Mayer A; Haas T; Kaser A; Feichtenschlager T; Fuchssteiner H; Knoflach P; Vogelsang H; Miehsler W; Platzer R; Tillinger W; Jaritz B; Schmid A; Blaha B; Dejaco C; Eichinger S
    Gastroenterology; 2010 Sep; 139(3):779-87, 787.e1. PubMed ID: 20546736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Genetic Aberrations in Thrombomodulin Gene in Patients With Recurrent Venous Thromboembolism.
    Ahmad A; Sundquist K; Zöller B; Svensson PJ; Sundquist J; Memon AA
    Clin Appl Thromb Hemost; 2017 May; 23(4):319-328. PubMed ID: 28049360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
    Rokx C; Borjas Howard JF; Smit C; Wit FW; Pieterman ED; Reiss P; Cannegieter SC; Lijfering WM; Meijer K; Bierman W; Tichelaar V; Rijnders BJA;
    PLoS Med; 2020 May; 17(5):e1003101. PubMed ID: 32407386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study.
    Kearon C; Spencer FA; O'Keeffe D; Parpia S; Schulman S; Baglin T; Stevens SM; Kaatz S; Bauer KA; Douketis JD; Lentz SR; Kessler CM; Moll S; Connors JM; Ginsberg JS; Spadafora L; Julian JA;
    Ann Intern Med; 2015 Jan; 162(1):27-34. PubMed ID: 25560712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event.
    Chaireti R; Rajani R; Bergquist A; Melin T; Friis-Liby IL; Kapraali M; Kechagias S; Lindahl TL; Almer S
    Thromb Res; 2014 Aug; 134(2):455-61. PubMed ID: 24913997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.
    Prandoni P; Noventa F; Ghirarduzzi A; Pengo V; Bernardi E; Pesavento R; Iotti M; Tormene D; Simioni P; Pagnan A
    Haematologica; 2007 Feb; 92(2):199-205. PubMed ID: 17296569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The study of the thrombin generation mechanism and the effect of low molecular weight heparin as thromboprophylaxis in patients undergoing total knee and hip replacement.
    Gionis MN; Ioannou CV; Katsamouris AN; Katonis P; Balalis K; Sfyridaki K; Elalamy I; Gerotziafas GT
    Thromb Res; 2013; 132(6):685-91. PubMed ID: 24182549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin generation in patients after acute deep-vein thrombosis.
    ten Cate-Hoek AJ; Dielis AW; Spronk HM; van Oerle R; Hamulyák K; Prins MH; ten Cate H
    Thromb Haemost; 2008 Aug; 100(2):240-5. PubMed ID: 18690343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.